| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.39 | 0.01 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |